van Winsen L - Search Results

1

CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis.

van Veen T, Crusius JB, van Winsen L, Xia B, Barkhof F, Salvador Peña A, Polman CH, Uitdehaag BM. van Veen T, et al. Among authors: van winsen l. J Neuroimmunol. 2003 Jul;140(1-2):188-93. doi: 10.1016/s0165-5728(03)00184-x. J Neuroimmunol. 2003. PMID: 12864988

2

Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.

Fabriek BO, Møller HJ, Vloet RP, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BM, van den Berg TK, Dijkstra CD. Fabriek BO, et al. Among authors: van winsen lm. J Neuroimmunol. 2007 Jul;187(1-2):179-86. doi: 10.1016/j.jneuroim.2007.04.016. Epub 2007 May 29. J Neuroimmunol. 2007. PMID: 17537523

3

Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.

van Winsen LM, Hooper-van Veen T, van Rossum EF, Koper JW, Barkhof F, Polman CH, Uitdehaag BM. van Winsen LM, et al. Among authors: van rossum ef. J Neuroimmunol. 2007 May;186(1-2):150-5. doi: 10.1016/j.jneuroim.2007.02.006. Epub 2007 Mar 28. J Neuroimmunol. 2007. PMID: 17395275

4

A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis.

van Winsen LM, Manenschijn L, van Rossum EF, Crusius JB, Koper JW, Polman CH, Uitdehaag BM. van Winsen LM, et al. J Clin Endocrinol Metab. 2009 Jun;94(6):2110-4. doi: 10.1210/jc.2008-2194. Epub 2009 Mar 24. J Clin Endocrinol Metab. 2009. PMID: 19318444

5

No association of Fc gamma RIIa, Fc gamma RIIIa and Fc gamma RIIIb polymorphisms with MS.

Breij EC, van der Pol WL, van Winsen L, Jansen MD, Dijkstra CD, van de Winkel JG, Uitdehaag BM. Breij EC, et al. Among authors: van winsen l, van der pol wl, van de winkel jg. J Neuroimmunol. 2003 Jul;140(1-2):210-5. doi: 10.1016/s0165-5728(03)00207-8. J Neuroimmunol. 2003. PMID: 12864991

6

The FAS-670 polymorphism influences susceptibility to multiple sclerosis.

van Veen T, Kalkers NF, Crusius JB, van Winsen L, Barkhof F, Jongen PJ, Peña AS, Polman CH, Uitdehaag BM. van Veen T, et al. Among authors: van winsen l. J Neuroimmunol. 2002 Jul;128(1-2):95-100. doi: 10.1016/s0165-5728(02)00163-7. J Neuroimmunol. 2002. PMID: 12098516

7

[Alpha]B-crystallin genotype has impact on the multiple sclerosis phenotype.

van Veen T, van Winsen L, Crusius JB, Kalkers NF, Barkhof F, Peña AS, Polman CH, Uitdehaag BM. van Veen T, et al. Among authors: van winsen l. Neurology. 2003 Nov 11;61(9):1245-9. doi: 10.1212/01.wnl.0000091861.27246.9e. Neurology. 2003. PMID: 14610128

8

No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.

Zwemmer JN, van Veen T, van Winsen L, van Kamp GJ, Barkhof F, Polman CH, Uitdehaag BM. Zwemmer JN, et al. Among authors: van winsen l, van veen t, van kamp gj. Mult Scler. 2004 Jun;10(3):272-7. doi: 10.1191/1352458504ms1010oa. Mult Scler. 2004. PMID: 15222690

9

Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis.

van Winsen LM, Muris DF, Polman CH, Dijkstra CD, van den Berg TK, Uitdehaag BM. van Winsen LM, et al. Among authors: van den berg tk. J Clin Endocrinol Metab. 2005 Feb;90(2):734-40. doi: 10.1210/jc.2004-0306. Epub 2004 Nov 16. J Clin Endocrinol Metab. 2005. PMID: 15546910

10

Outcome measurement in multiple sclerosis: detection of clinically relevant improvement.

van Winsen LM, Kragt JJ, Hoogervorst EL, Polman CH, Uitdehaag BM. van Winsen LM, et al. Mult Scler. 2010 May;16(5):604-10. doi: 10.1177/1352458509359922. Epub 2010 Jan 19. Mult Scler. 2010. PMID: 20086019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters